1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

In this week's It’s Debatable article, Rosen and Moster debate if President Trump's foreign policy actions have increased the ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026Phase 1 protocol allows multiple solid tumor types known to express ...

Leading manufacturers are responding not with generic devices, but with precisely engineered solutions tailored to distinct ...